BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

802 related articles for article (PubMed ID: 18187290)

  • 21. Imaging to differentiate between ischemic and nonischemic cardiomyopathy.
    Bax JJ; Poldermans D; Schuijf JD; Scholte AJ; Elhendy A; van der Wall EE
    Heart Fail Clin; 2006 Apr; 2(2):205-14. PubMed ID: 17386890
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement.
    Casolo G; Minneci S; Manta R; Sulla A; Del Meglio J; Rega L; Gensini G
    Am Heart J; 2006 Jan; 151(1):101-8. PubMed ID: 16368300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR).
    Vöhringer M; Mahrholdt H; Yilmaz A; Sechtem U
    Herz; 2007 Mar; 32(2):129-37. PubMed ID: 17401755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of normal adenosine-stress cardiac magnetic resonance imaging.
    Pilz G; Jeske A; Klos M; Ali E; Hoefling B; Scheck R; Bernhardt P
    Am J Cardiol; 2008 May; 101(10):1408-12. PubMed ID: 18471450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Navigator-gated 3D blood oxygen level-dependent CMR at 3.0-T for detection of stress-induced myocardial ischemic reactions.
    Jahnke C; Gebker R; Manka R; Schnackenburg B; Fleck E; Paetsch I
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):375-84. PubMed ID: 20394899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy.
    Calore C; Cacciavillani L; Boffa GM; Silva C; Tiso E; Marra MP; Bacchiega E; Corbetti F; Iliceto S
    J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):821-9. PubMed ID: 17885521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peri-infarct ischemia determined by cardiovascular magnetic resonance evaluation of myocardial viability and stress perfusion predicts future cardiovascular events in patients with severe ischemic cardiomyopathy.
    Tsukiji M; Nguyen P; Narayan G; Hellinger J; Chan F; Herfkens R; Pauly JM; McConnell MV; Yang PC
    J Cardiovasc Magn Reson; 2006; 8(6):773-9. PubMed ID: 17060098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging.
    Cummings KW; Bhalla S; Javidan-Nejad C; Bierhals AJ; Gutierrez FR; Woodard PK
    Radiographics; 2009; 29(1):89-103. PubMed ID: 19168838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between contrast echocardiography and magnetic resonance imaging to predict improvement of myocardial function after primary coronary intervention.
    Biagini E; van Geuns RJ; Baks T; Boersma E; Rizzello V; Galema TW; de Feyter PJ; ten Cate FJ
    Am J Cardiol; 2006 Feb; 97(3):361-6. PubMed ID: 16442396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.
    Mahrholdt H; Wagner A; Judd RM; Sechtem U; Kim RJ
    Eur Heart J; 2005 Aug; 26(15):1461-74. PubMed ID: 15831557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular magnetic resonance findings in typical versus atypical forms of the acute apical ballooning syndrome (Takotsubo cardiomyopathy).
    Haghi D; Fluechter S; Suselbeck T; Kaden JJ; Borggrefe M; Papavassiliu T
    Int J Cardiol; 2007 Aug; 120(2):205-11. PubMed ID: 17175045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance myocardial perfusion imaging-First experience at 3.0T.
    Klumpp B; Hoevelborn T; Fenchel M; Stauder NI; Kramer U; May A; Gawaz MP; Claussen CD; Miller S
    Eur J Radiol; 2009 Jan; 69(1):165-72. PubMed ID: 18024045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance contrast enhancement with gadolinium-DTPA in patients with angina and angiographically normal coronary arteries: effect of chronic beta-blockade.
    Rossetti E; Fragasso G; Mellone R; Vanzulli A; Del Maschio A; Chierchia SL
    Cardiologia; 1999 Jul; 44(7):653-9. PubMed ID: 10476591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T; Lüdemann L; Rudolph B; Rehbein H; Staack A; Taupitz M; Prochnow D; Beyersdorff D
    Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of transmural extent of infarction with contrast echocardiographically derived index of myocardial blood flow and myocardial blood volume fraction: comparison with contrast-enhanced magnetic resonance imaging.
    Choi EY; Seo HS; Park S; Kim HJ; Ahn JA; Ko YG; Choi BW; Kang SM; Choi D; Ha JW; Rim SJ; Jang Y; Chung N
    J Am Soc Echocardiogr; 2006 Oct; 19(10):1211-9. PubMed ID: 17000359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concepts of myocardial perfusion imaging in magnetic resonance imaging.
    Wilke N; Jerosch-Herold M; Stillman AE; Kroll K; Tsekos N; Merkle H; Parrish T; Hu X; Wang Y; Bassingthwaighte J
    Magn Reson Q; 1994 Dec; 10(4):249-86. PubMed ID: 7873354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease.
    Syed IS; Martinez MW; Feng DL; Glockner JF
    Int J Cardiol; 2008 Jun; 126(3):e50-2. PubMed ID: 17399811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of dual to single contrast bolus magnetic resonance myocardial perfusion imaging for detection of significant coronary artery disease.
    Groothuis JG; Kremers FP; Beek AM; Brinckman SL; Tuinenburg AC; Jerosch-Herold M; van Rossum AC; Hofman MB
    J Magn Reson Imaging; 2010 Jul; 32(1):88-93. PubMed ID: 20578015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease.
    Watkins S; McGeoch R; Lyne J; Steedman T; Good R; McLaughlin MJ; Cunningham T; Bezlyak V; Ford I; Dargie HJ; Oldroyd KG
    Circulation; 2009 Dec; 120(22):2207-13. PubMed ID: 19917885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Usefulness of parametric imaging-based quantitative myocardial contrast echocardiography in predicting the functional recovery of akinetic segments following primary angioplasty in acute myocardial infarction patients].
    Serra V; Pérez de Isla L; Zamorano J; Almería C; Rodrigo JL; Pérez M; Florit J; Azcona L; Hernández RA; Macaya C
    Rev Esp Cardiol; 2005 Jun; 58(6):649-56. PubMed ID: 15970120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.